At present, recombinant adeno-associated virus is the most commonly used vectors for in vivo gene therapy products. For producing virus vectors, plasmids are believed to be the important starting raw material. The designing and managing of plasmids directly contribute to the biological mechanisms, pharmaceutical properties, efficacy, and safety of products. Therefore, understanding the properties of plasmids and their gene elements is the basis for the “quality by design” of such products. The functions of different plasmids are introduced in this paper, the construction of main genetic elements are summarized, the considerations for designing of plasmids are discussed, the compliance for developing and manufacturing of plasmids are reviewed, in order to provide some references for the development and management of gene therapy products, especially for the recombinant adeno-associated virus products.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |